The data presented clearly suggest that relative amounts of mRNAs for elastins a, b and c are developmentally regulated in foetal-calf nuchal ligament and aorta and that this regulation is tissue-specific. In nuchal ligament, at earlier stages of foetal development, the relative amounts of mRNAs for elastins a and b are very low. After the foetal age of about 6 months the relative amount of mRNA for elastin b begins to increase. This is followed by an increase in the relative amount of mRNA for elastin a. In aorta, with increasing foetal age, the relative amounts of mRNAs for elastins b and c increase and decrease alternately. The relative amounts of mRNA for elastin a remain low, with only marginal increases with foetal age. A possible self-aggregation role of elastin a in elastogenesis is proposed.
INTRODUCTION
Elastin has the property of elastic recoil and is the major component of those tissues which require rapid extension and complete recovery (e.g. aorta and nuchal ligament). The polypeptide chains of elastin are crosslinked at suitable intervals and this generates an extensible three-dimensional network. It has been reported that the production of elastin is very low at early stages of foetal elastic-tissue development (nuchal ligament and aorta) and that there is a marked increase in the synthesis and appearance of elastin in these tissues at later stages of foetal development [1, 2] .
Very recently, we reported the occurrence of three mRNAs for elastin in foetal calf nuchal ligament, encoding three forms of elastin (a, b and c). These forms are the result of the presence, at a single position, of 102 addition nucleotides in the mRNA for elastin a and of 60 of these nucleotides in the mRNA for elastin b as compared with the mRNA for elastin c [3] . Since then, others have also reported the occurrence of multiple forms of mRNA for elastin [4, 5] . We have now examined the relative abundance of these three mRNAs for elastin in nuchal ligament and aorta of foetal calves at various stages of foetal development. The results of this study are reported in the present paper.
EXPERIMENTAL Materials
Chemicals. Guanidinium thiocyanate was bought from Fluka (Terrochem, Mississauga, Ont., Canada); guanidinium chloride (Ultra-pure) was from Gibco/BRL (Burlington, Ont., Canada). Biodyne nylon membrane, [y-32P]ATP and poly(ethylene glycol) 8000 were from ICN (St. Laurent, Que., Canada). Dithiothreitol (DTT) and AG 501-X8(D) mixed-bed resin (analytical grade) were from Bio-Rad (Mississauga, Ont. Canada). Sodium N-d-odecylsarcosine, heparin (sodium salt), chloramphenicol, agar Vol. 261 
Methods
Isolation of total RNA. The total cellular RNA was isolated from the nuchal ligaments and aortas by slight modification of the previously described guanidinium thiocyanate/guanidinium chloride extraction method [6] . After the fourth precipitation with 0.7 vol. of ethanol, the pellet was resuspended in a minimum volume of resuspension buffer (6.0 M-guanidinium chloride/l0 mM-DTT/ 1.000 sodium N-dodecylsarcosine/20 mM EDTA/0.1 MTris/HCl, pH 5.5 (no less than 3.0 ml) and extracted with an equal volume ofchloroform/phenol (1: 1, v/v). Before use, the phenol was water-saturated, then equilibrated with 10 mM-Tris/HCI/ 1.0 mM-EDTA, pH 8.0, and contained 0.5 mg/ml of quinolinol to give the phenol phase a yellow colour, which helped in revealing the two phases in the extraction mixture. The top aqueous phase was removed and the phenol phase was re-extracted with resuspension buffer. The acqueous phases from both extractions were pooled and extracted with an equal volume of chloroform. The aqueous phase from the chloroform extraction was then treated with an equal volume of water-saturated diethyl ether to remove traces of remaining phenol. The aqueous phase from the diethyl ether extraction was placed in a vacuum desiccator to remove residual ether by evaporation under reduced pressure. Finally, the RNA was pelleted and stored as described previously [7] .
Assay of mRNAs for Elastin a, b and c. Probes. Two chemically synthesized oligodeoxyribonucleotides (Applied Biosystems 380B DNA Synthesizer), 25-mers (for sequences, see the abbreviations footnote), one complementary to a sequence unique to the mRNA for elastin a (oligo A) and the other complementary to a sequence present in the mRNAs for elastin a and b (oligo B), were used as probes to quantify the mRNAs for elastin a and elastins a and b respectively. The PstI fragment from clone pcBE319 (392 bp) (Pst: 319) [3] , which carries the sequences common to all three mRNAs of elastin (a, b and c), served as a probe for these mRNAs.
Labelling. The synthetic oligomers (oligo A and oligo B) were labelled with the use of a T4 polynucleotide kinase reaction as follows: 100 ng of the oligonucleotide were added to 70 mM-Tris/HCl (pH 7.5)/10 mMMgCl2/7 mM-DTT/[y-32P]ATP (800Ci) and incubated at 37°C for 30 min in the presence of 20 units of T4 polynucleotide kinase. Pst: 319 was nick-translated and labelled with [a-32P]dCTP (specific radioactivity > 3000 Ci/mmol) as described in the literature [8] . Pst: 319 was also inserted into vector MI 3mp'8 and was labelled by a second-strand-synthesis reaction with the use of the hybridization probe primer (Biolabs, no. 1202) which produces a radiolabelled second strand [9] . The unincorporated radiolabel was removed by chromatography of the labelled probe on a Sephadex G-100 column pre-equilibrated with elution buffer [100 mMNaCl/lO mM-Tris/HCl (pH 8.0)/1 mM-EDTA].
Dot-blot analysis. Various amounts of total RNA from nuchal ligament and aorta were made to a final volume of 120ul with 20xSSC (1 xSSC is 150mM-NaCl/75 mM-sodium citrate, pH 7.0), denatured by heating at 70°C for 5 min and chilled on ice for 3 min before application on to nitrocellulose membranes. Nitrocellulose membranes were prepared as described in [10] . Specificity of probes used for dot-blot and Northern-blot analysis (a) Dot-blot hybridization: 5.0 ng of cDNA clones pcBE308, pcBE319 and pcBE320 [3] were blotted on to nitrocellulose filters and hybridized with radiolabelled probes as indicated: 1, pcBE308, 2, pcBE319; 3, pcBE320; 4, pBR322. Clone pcBE308 contains 102 additional nucleotides (corresponding to elastin a) and pcBE320 contains 60 of these nucleotides (corresponding to elastin b) as compared with clone pcBE319 (corresponding to elastin c).
(b) Northern-blot analysis: 10 ,ug of total RNA was denatured, electrophoresed on a 1.0%-agarose gel and transferred to hybridizing membranes as described in the Experimental section. Lanes Northern-blot analysis. The total RNA preparations from nuchal ligament of an 8-month-old-foetus and aorta of a 9-month-old foetus were denatured with the use of the dimethyl sulphoxide/glyoxal -method [13] . Briefly, 10 ,g of RNA were incubated in 10 10 mM-sodium phosphate and 0.08% Bromophenol Blue and electrophoresed at 70 V on a 1.0 %-agarose gel containing 10 mM-sodium phosphate, pH 7.0, for 3 h at room temperature. The running buffer was circulated between the two electrophoresis-buffer wells. The lanes containing the wheatgerm rRNA size markers [14] were removed, stained with Acridine Orange and destained as described by McMaster & Carmichael [15] .
The specificity of each probe for the mRNAs of elastin a, b and c was demonstrated by one of three ways. (i) Capillary transfer of RNA: the RNA-containing gel was soaked in 0.25 M-NaOH/ 1.5M-NaCl for 30 min, then neutralized in 0.5 M-Tris/HCl buffer, pH 7.0, for 30 min [16] and transferred to nitrocellulose of GeneScreen Plus overnight as described by Maniatis [11] . The filters were air-dried and baked under vacuum at 80°C for 2 h. (ii) Electroblotting of RNA: electrophoretic transfer of RNA to nylon membrane-was performed in 25 mM-sodium phosphate buffer, pH:7.0 according to the manufacturer's (Bio-Rad) instructions. The apparatus was pre-chilled to 4°C and the transfer was carried out at 4 IC with 0.22 A for 2 h and then with 0.45 A for 4 h. The filters were pre-hybridized and washed as described for the dot-blot analysis. (iii) Hybridization in situ: Hybridization was carried out essentially as described in [17] . After hybridization, the membranes and gels were covered in plastic wrap and exposed to Kodak X-Omat AR film for 3-5 days at -80°C with the use of a Corning intensifying screen.
RESULTS AND DISCUSSION
The specificity of the three probes {oligo A, 5'-GTTTTGTAGGGCAGTCCATAGCCAG-3', complementary to a sequence unique to the mRNA for elastin a; oligo b, 5'-TCCCCGTTGGATACCCAGCCTTGCC-3', complementary to a sequence present in mRNAs for elastin a and b; the PstI fragment of pcBE319 (Pst: 319), complementary to the sequence common to all three forms of mRNA for elastin (a, b and c) [3] } was examined by dot-blot hybridization with clones pcBE308, pcBE320 and pcBE319 and also by Northern-blot analysis of total RNA isolated from nuchal ligament and aorta. The results are shown in Fig. 1. As Fig. 1(a) shows, oligo A hybridizes with clone pcBE308 only; oligo B hybridized with pcBE308 and pcBE320, but did not hybridize with pcBE319. Pst: 319 hybridized with all three clones, but not with pBR322. As Fig. 1(b) shows, only one radioactive band was observed in the RNA preparations from both tissues (with the mobility corresponding to the mobility of elastin mRNA [3] ) with each of the three probes. Thus it is safe to assume that the probes are specific for the complementary sequences present in the mRNAs for elastin a, b and c. The results in Fig. 1 (b) also show that the mRNAs for elastin were essentially intact.
Autoradiographs of dot-blot hybridization analysis of RNA preparations of nuchal ligament at various stages of foetal-calf development are shown in Fig. 2(a) and those Qf aorta in Fig. 2(b) . The line labelled 'oligo A' measures the relative amounts of mRNA for elastin a, the 'oligo B' line measures the relative amounts of mRNA for elastin a and b, and the line 'Pst: 319' measures the amounts of mRNA for all three forms of elastin at Fig. 3(a) , the relative amounts of total mRNAs for elastin (a + b + c) in nuchal ligament was low until the foetal age of about 6.5 months and began to rise rapidly thereafter. This pattern is similar to that observed for the appearance of insoluble elastin in foetal-calf nuchal ligament [1] . Thus our data confirm an earlier report that elastin synthesis and deposition in nuchal ligament parallel the amounts of mRNA for elastin [18] . aggregation. Elastin c will fulfil this requirement. At later stages of foetal development the elastin fibres in the nuchal ligament increase in diameter by depositing elastin on the existing fibres [19] . This requires self-aggregation, and elastin a may be involved in this process. The data shown in Fig. 3 (b) are consistent with this hypothesis. As shown in Fig. 4(a) , there was a noticeable increase in the relative amounts of the total mRNAs for elastin a, b and c in aorta after the foetal age of about 5 months. After this increase only small differences in the amounts of total mRNAs for elastin were observed. Fig. 4(b) shows the relative amounts of mRNAs for elastin a, b and c at various stages of foetal development. At about 3 months the relative amounts of mRNA for elastin c is higher than those of the mRNA for elastin a and b. With increasing foetal age the relative amounts of mRNAs for elastin b and c increase and decrease alternately. The relative amounts of mRNA for elastin a remains low, with only marginal increases with foetal age. It may be mentioned that the nuchal ligament is a relatively simple structure with its structural elements aligned with the longitudinal axis of the tissue and its elastin component constitutes about 80 % of the total dry weight of tissue [20] . In contrast, the structure of aorta is more complex. In this tissue, elastin is arranged in cylindrical layers in the form of fenestrated sheets and fibres [21] and constitutes about 40 % of its dry weight [22] . The degree of selfaggregation required for the formation of these structures would be significantly lower than that for nuchal ligament. This may explain the lower amounts of mRNA for elastin a observed in aorta. In any case, the data clearly suggest that the expression of the mRNAs for elastin a, b and c is developmentally regulated and that this regulation is tissue-specific. The relative amounts of elastin a, b and c at various developmental stages of bovine nuchal ligament are shown in Fig. 3(b) . At earlier stages of foetal development the relative amounts of mRNAs for elastin a and b are very low. After the foetal age of about 6 months the relative amount ofmRNA for elastin b begins to increase. This is followed by the increase in the relative amount of mRNA for elastin a (after foetal age of about 7 months). The insertion sequence present in elastin a (missing from elastin c) has one very interesting feature: it is relatively rich in tyrosine residues [3] . Four of the total of seven tyrosine residues, encoded by the mRNA for elastin a, occur in this insertion sequence. It is tempting to speculate that this region may promote intermolecular aggregation and thus may play a role in elastogenesis. At early stages of development, elastin molecules appear around microfibrillar components [19] and thus need to avoid self-
